Former FDA Officials Say Fosamax Claims Aren't Barred
By Emily Field · May 30, 2023, 6:42 PM EDT
Former U.S. Food and Drug Administration officials told the Third Circuit if it rules that patients' claims that Merck failed to warn that its osteoporosis drug Fosamax caused certain fractures are...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login